Enorden
Brand names,
Enorden
Analogs
Enorden
Brand Names Mixture
Enorden
Chemical_Formula
C20H23NS
Enorden
RX_link
No information avaliable
Enorden
fda sheet
Enorden
msds (material safety sheet)
Enorden
Synthesis Reference
No information avaliable
Enorden
Molecular Weight
309.469 g/mol
Enorden
Melting Point
< 25 oC
Enorden
H2O Solubility
Soluble as HCl salt
Enorden
State
Liquid
Enorden
LogP
5.7
Enorden
Dosage Forms
Tablets (oral, 1 mg)
Enorden
Indication
Used for the symptomatic treatment of parkinsonism.
Enorden
Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Enorden
Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Enorden
side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Enorden
Patient Information
Enorden
Organisms Affected
Humans and other mammals